Pharmaceuticals, organic chemistry, pharmaceutical formulations, biochemistry
Hiroshi Morita
Partner
Mr. Morita has extensive IP experience in the life-science field cultivated in a pharmaceutical company, where he secured exclusivity through utilization of Intellectual property in areas as diverse as worldwide patent filing, prosecution, liaison, litigation, patent evaluation for in-licensing, patent strategies, etc.
Profession
Patent Attorney
Admissions
Japan Patent Attorneys Association (1989)
Membership
Japan Patent Attorneys Association
Intellectual Property Strategy Headquarters (advisory body to the Cabinet of Prime Minister Abe),
IP dispute resolution system committee member (2015-2016)
Japan Intellectual Property Association (JIPA), Vice President (2015-2016)
Japan Pharmaceutical Manufacturers Association (JPMA) IP committee, Vice president (2012-2016)
Japan Intellectual Property Association (JIPA), Managing Director (2014-2015)
Areas of Legal Expertise
Patent and utility model applications, trials and appeals, expert opinions, and litigation
Areas of Technological Expertise
Professional Experience
2016 – present – Sonderhoff & Einsel, Law and Patent Office
1984 – 2016 – Astellas Pharma Inc.(previously: Yamanouchi Pharmaceutical Co., Ltd.)
Education
2006 – 2008 – Hitotsubashi University, International Corporate Strategy, MSc
1982 – 1984 – Kyushu University, Pharmaceutical Science, MSc
1982 – Kyushu University, Pharmaceutical Science
Publications
Update of Patent Linkage System for Pharmaceutical Products in China and Taiwan ( Vol. 70 No. 6 2020 of “Chizai Kanri “, Co-author: Hiroshi Morita) 2020
“Patent Strategy and the Trend in Developing Technologies for Drug Modalities” (The Technical Information Institute Co., Ltd., p549-555, Co-author: Hiroshi Morita etc.) May 31, 2019
“4 Global Business Expansion and IP Management in the Pharmaceutical Industry” (“Institute of Intellectual Property Forum, 2015, Spring, Vol. 101, Special Feature: “Japanese Company Overseas Business Expansion and IP Strategies/ Issues and Responses in IP Negotiations” pp. 4-7, Institute of Intellectual Property) 2015
Lectures
“From the Ground Up: The Latest IP Information Related to Pharmaceutical Patents such as the China/Taiwan Patent Linkage System”(Johokiko Co., Ltd) August 2018
“Employee Inventions in Germany and Japan” (EU-Japan Centre for Industrial Cooperation) 2016
Languages
Japanese, English
